West Pharmaceutical Services Finance Lease Principal Payments remained flat by 0.0% to $300.00K in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 50.0%, from $200.00K to $300.00K. This decline may warrant attention — for this metric, higher values are generally preferred.
Higher payments indicate a faster reduction of lease-related debt, which improves the balance sheet over time.
The portion of finance lease payments applied to reduce the outstanding principal balance of the lease liability. This m...
Standard disclosure for companies utilizing finance leases for capital assets.
other_finance_lease_principal_payments| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $100.00K | $100.00K | $22.90M | $300.00K | $100.00K | $200.00K | $300.00K | $300.00K | $300.00K | $300.00K |
| QoQ Change | — | — | — | — | — | — | — | — | +0.0% | >999% | -98.7% | -66.7% | +100.0% | +50.0% | +0.0% | +0.0% | +0.0% |
| YoY Change | — | — | — | — | — | — | — | — | — | — | — | +0.0% | +100.0% | -98.7% | +0.0% | +200.0% | +50.0% |